Navigation Links
ESCEO-IOF Servier Pierre D. Delmas Prize awarded to John. A. Kanis
Date:3/23/2011

Today, at the opening of the European Congress on Osteoporosis & Osteoarthritis in Valencia, Spain, Professor John A. Kanis was awarded the 2nd ESCEO-IOF Servier Pierre D. Delmas Prize.

The prestigious award, granted by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) with the support of Servier, honours an individual who has made outstanding and major scientific contributions to the study of bone and mineral diseases. Consisting of a grant of 40,000 and an honorary medal, the award is named after the late Pierre Delmas, Professor of Medicine and Rheumatology at the University of Lyon, France, and Director of the INSERM research unit 'Pathophysiology of Osteoporosis'. Professor Delmas was an outstanding scientist who directed essential basic and clinical research in metabolic bone diseases. He was one of the leading proponents of osteoporosis advocacy worldwide in his role as IOF President.

Prof. John A. Kanis is currently the Emeritus Professor in Human Metabolism and Clinical Biochemistry and the Director of the WHO Collaborating Centre for Metabolic Bone Diseases, University in Sheffield, UK. Prof. Kanis' research interests are largely related to disorders of skeletal metabolism including osteoporosis, Paget's disease of bone, hyperparathyroidism, renal osteodystrophy and neoplasia affecting the skeleton. He has also made a number of national and international contributions to guideline development, health technology assessment, epidemiology and health economics. Prof. Kanis is President of the International Osteoporosis Foundation and WHO Advisor on Osteoporosis, among other honorary positions. He is Co Editor-in-Chief of Osteoporosis International, serves on the editorial board of several journals and is the author of more than 800 papers, chapters and books on bone disease and metabolism. His current major interest is in the development
'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1 2

Related biology news :

1. Inaugural Herbert A. Fleisch ESCEO-IOF Medal is awarded to Professor Gerard Karsenty
2. ESCEO-IOF-ABBH Young Investigator Awards recognize research excellence
3. Sam Safran wins EPJE -- Pierre-Gilles De Gennes Lecture Prize
4. Winner of Pierre Delmas Prize announced at World Congress on Osteoporosis 2010
5. UW-Madison lake scientist gets worlds top water prize
6. Heinz Maier-Leibnitz Prizes 2011: Recognition and incentive for early career researchers
7. Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize
8. An Israel prize in his genes
9. Winners to share $1 million prize in Office of Naval Research challenge
10. Filmmakers Joel and Ethan Coen among 2011 Dan David Prize winners
11. Vilcek Foundation names recipients of 2011 Vilcek Prizes in Biomedical Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... MOUNTAIN VIEW, Calif. , Aug. 5, 2015 /PRNewswire/ ... it exhibits continuous growth in applications, penetration into newer ... year after year. The global biosensors space has seen ... having exited the market so far. (Photo ... from Frost & Sullivan, Analysis of the Global ...
(Date:8/4/2015)... (NASDAQ: AMRI ) today reported financial and operating results for ... , Second quarter contract revenue of $ 85.2 ... Adjusted contract margins of 26 % , ... in EPS from royalties in the current quarter , ... are very pleased to present another strong financial quarter, with all ...
(Date:7/31/2015)... , Kina, 31. juli 2015 Den 10. ... afholdt af BGI fra den 22. - 25. oktober i ... Konferencen fejrer sin 10-års fødselsdag i år. Siden starten ... indflydelsesrige årlige møder på ,omik,-feltet, og er en af ... ICG-10 fokuserer på nylige gennembrud og fremskridt ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... new molecular signature for a destructive and often lethal pediatric ... the hard-to-treat condition. In a study that included human ... in the November Journal of Clinical Investigation that ... process. Some patients have a second molecular conductor of disease ...
... A human monoclonal antibody developed by MassBiologics of ... patients with chronic hepatitis C virus (HCV) infection undergoing ... a week after transplant and delayed the time to ... 2 study were presented this week at The Liver ...
... Researchers studying the nature of crowds playing Foldit called ... of the methods already used by protein scientists., Gamers ... a protein central to research on AIDS. Today, ... of the National Academy of Sciences, University of ...
Cached Biology News:Possible treatment target found for main cause of severe liver disease in kids 2Possible treatment target found for main cause of severe liver disease in kids 3Experimental drug suppresses rebound of hepatitis C virus in liver transplant patients 2Experimental drug suppresses rebound of hepatitis C virus in liver transplant patients 3Paper uncovers power of Foldit gamers' strategies 2Paper uncovers power of Foldit gamers' strategies 3
(Date:9/3/2015)... 2015 According to a new ... (HPLC, UHPLC, Flash), GC, Other Components (Autosamplers, Detectors, Fraction ... - Analysis & Global Forecasts to 2020", published by ... around 9.223 Billion by 2020 from USD 7.062 Billion ... Browse 141 tables and 36 figures spread through 277 ...
(Date:9/2/2015)... 2, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Nanobiotechnology ... offering. An increasing use ... industries is anticipated. Nanotechnology will be applied ... from formulations for optimal delivery to diagnostic ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
(Date:9/2/2015)... CUMBERLAND, R.I. , Sept. 2, 2015 /PRNewswire/ ... has been enrolled in the multicenter Phase 2 ... for the long-term treatment of recurrent subfoveal choroidal ... AMD).  NT-503 is a unique vascular endothelial growth ... versatile ECT implant. "This landmark proof-of-concept ...
Breaking Biology Technology:Chromatography Instruments Market Worth $ 9.223 Billion by 2020 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 4Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4
... of the equation , ,Identity theft has seen the ... three years. The United States is faced with an ever-changing ... both sides of the equation, organizational and consumer. , ... to a new report from the Federal Trade Commission (FTC). ...
... pioneer company looks to reclaim lost ground , ,CHIPPEWA FALLS, ... operating out of offices on Lowater Road here in its hometown, ... wonderful heights. , ,With its next-generation X1, on the market since ... toward the future with a twinkle in its corporate eye that, ...
... often been regarded as the economic motor of the European ... of Scandinavia, to the east of the U.K. and France, ... the east European countries of Poland, the Czech Republic and ... not only one of Europes largest populations but considering ...
Cached Biology Technology:Are You Ready for Identity Theft? 2Are You Ready for Identity Theft? 3Are You Ready for Identity Theft? 4Are You Ready for Identity Theft? 5Are You Ready for Identity Theft? 6Are You Ready for Identity Theft? 7Cray Rides Again 2Cray Rides Again 3German Life Science Oktoberfest Comes to the Midwest 2German Life Science Oktoberfest Comes to the Midwest 3German Life Science Oktoberfest Comes to the Midwest 4German Life Science Oktoberfest Comes to the Midwest 5German Life Science Oktoberfest Comes to the Midwest 6
...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
Goat anti-VAV2 Class: Antibody Product Group: Miscellaneous Antibody...
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Biology Products: